AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34397205 — intervention group
Group type: EXPERIMENTAL
Intervention: guselkumab 100 mg every-8-weeks
Number of subjects: 1721
Study 36263546 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligasure vessel sealing system (LVSS)
Number of subjects: 68
Study 36263546 — intervention group
Group type: COMPARATOR
Intervention: Conventional knot tying
Number of subjects: 68
Study 32602793 — intervention group
Group type: EXPERIMENTAL
Intervention: Blackcurrant extract (300 mg/d, 105 mg/d anthocyanin)
Number of subjects: 15
Study 32602793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 32243717 — intervention group
Group type: EXPERIMENTAL
Intervention: StressProffen (app-based intervention)
Number of subjects: 172
Study 32243717 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 172
Study 36266534 — intervention group
Group type: COMPARATOR
Intervention: captopril/placebo
Number of subjects: 50
Study 36266534 — intervention group
Group type: COMPARATOR
Intervention: telmisartan/placebo
Number of subjects: 50
Study 36266534 — intervention group
Group type: EXPERIMENTAL
Intervention: captopril + telmisartan
Number of subjects: 50
Study 36266534 — intervention group
Group type: COMPARATOR
Intervention: placebo/placebo
Number of subjects: 50
Study 34916637 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealing group (RMGIC without caries removal)
Number of subjects: 93
Study 34916637 — intervention group
Group type: EXPERIMENTAL
Intervention: Restoration group (RMGIC with selective caries removal)
Number of subjects: 93
Study 32747412 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 19114
Study 32747412 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study 32747412 — intervention group
Group type: COMPARATOR
Intervention: Not on aspirin
Number of subjects: 19114
Study 35408390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive task (counting down in threes from a randomly assigned number between 95 and 100) during mCTSIB
Number of subjects: 10
Study 35408390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive task during mCTSIB
Number of subjects: 10
Study 35408390 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural sway jerk
Number of subjects: 10
Study 32866850 — intervention group
Group type: EXPERIMENTAL
Intervention: HDM allergen positive patients
Number of subjects: 100
Study 32866850 — intervention group
Group type: COMPARATOR
Intervention: All patients (including HDM positive and negative)
Number of subjects: 100
Study 35063007 — intervention group
Group type: EXPERIMENTAL
Intervention: Same day discharge with ongoing telemonitoring up to 7 days after surgery
Number of subjects: 200
Study 35063007 — intervention group
Group type: COMPARATOR
Intervention: Standard of in-hospital care with discharge on the first postoperative day
Number of subjects: 200
Study 36041758 — intervention group
Group type: EXPERIMENTAL
Intervention: ASICA intervention (tablet-based intervention designed to support monthly TSSE)
Number of subjects: 104
Study 32705811 — intervention group
Group type: COMPARATOR
Intervention: Counselling from care providers about nutrition and physical activity
Number of subjects: 66
Study 32705811 — intervention group
Group type: COMPARATOR
Intervention: Women's beliefs and values regarding weight gain
Number of subjects: 66
Study 32705811 — intervention group
Group type: COMPARATOR
Intervention: Access to information on safe physical activity in pregnancy
Number of subjects: 66
Study 32705811 — intervention group
Group type: COMPARATOR
Intervention: Competing priorities
Number of subjects: 66
Study 32705811 — intervention group
Group type: COMPARATOR
Intervention: Pregnancy symptoms (fatigue and nausea)
Number of subjects: 66
Study 35831082 — intervention group
Group type: EXPERIMENTAL
Intervention: Short list of essential medicines provided free of charge
Number of subjects: 379
Study 35831082 — intervention group
Group type: EXPERIMENTAL
Intervention: Short list of essential medicines
Number of subjects: 379
Study 35578276 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital alcohol intervention
Number of subjects: 2129
Study 35578276 — intervention group
Group type: COMPARATOR
Intervention: Alcohol information (control)
Number of subjects: 2129
Study 33836963 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia (R group)
Number of subjects: 80
Study 33836963 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia (L group)
Number of subjects: 80
Study 34153231 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose induction adalimumab (2·4 mg/kg at weeks 0 and 1)
Number of subjects: 93
Study 34153231 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose induction adalimumab (2·4 mg/kg at week 0 and placebo at week 1)
Number of subjects: 93
Study 34153231 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose maintenance adalimumab (0·6 mg/kg weekly)
Number of subjects: 93
Study 34153231 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose maintenance adalimumab (0·6 mg/kg every other week)
Number of subjects: 93
Study 34153231 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled adalimumab groups (high-dose and standard-dose)
Number of subjects: 93
Study 34153231 — intervention group
Group type: COMPARATOR
Intervention: Placebo (external comparison)
Number of subjects: 93
Study 34779246 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafamidis
Number of subjects: 441
Study 34779246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441
Study 32972404 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized video feedback (IVF)
Number of subjects: 60
Study 32972404 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised video feedback (UVF)
Number of subjects: 60
Study 32972404 — intervention group
Group type: COMPARATOR
Intervention: Direct expert feedback (DEF)
Number of subjects: 60
Study 35057489 — intervention group
Group type: EXPERIMENTAL
Intervention: 11 g of BiotisTM GOS
Number of subjects: 132
Study 35057489 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.5 g of BiotisTM GOS
Number of subjects: 132
Study 35057489 — intervention group
Group type: COMPARATOR
Intervention: Control product
Number of subjects: 132
Study 34117528 — intervention group
Group type: EXPERIMENTAL
Intervention: 3× weekly bicycle ergometer training during HD for 12 weeks
Number of subjects: 54
Study 34117528 — intervention group
Group type: COMPARATOR
Intervention: No training during HD for 12 weeks (control group)
Number of subjects: 54
Study 33152450 — intervention group
Group type: EXPERIMENTAL
Intervention: artemisinin-piperaquine (AP)
Number of subjects: 41
Study 33152450 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 41
Study 33152450 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 41
Study 34473842 — intervention group
Group type: EXPERIMENTAL
Intervention: WaveOne Gold (size 35, .06 taper)
Number of subjects: 30
Study 34473842 — intervention group
Group type: EXPERIMENTAL
Intervention: TRUShape (size 30, .06v taper)
Number of subjects: 30
Study 34473842 — intervention group
Group type: COMPARATOR
Intervention: XP‐endo Shaper
Number of subjects: 30
Study 34473842 — intervention group
Group type: EXPERIMENTAL
Intervention: WaveOne Gold
Number of subjects: 30
Study 34473842 — intervention group
Group type: EXPERIMENTAL
Intervention: TRUShape
Number of subjects: 30
Study 32371534 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral subthalamic nucleus deep brain stimulation (STN-DBS)
Number of subjects: 151
Study 32371534 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care medical treatment (MED)
Number of subjects: 151
Study 34967863 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia patient education platform
Number of subjects: 100
Study 34967863 — intervention group
Group type: COMPARATOR
Intervention: Traditional patient education methods via clinical visits
Number of subjects: 100
Study 34294842 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservative-free latanoprost
Number of subjects: 51
Study 34294842 — intervention group
Group type: COMPARATOR
Intervention: Preserved latanoprost
Number of subjects: 51
Study 34294842 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study 35984848 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up assessments at 24 months
Number of subjects: 0
Study 32007523 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light therapy (IPL) - five flashes
Number of subjects: 87
Study 32007523 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light therapy (IPL) - four flashes
Number of subjects: 87
Study 32007523 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 87
Study 33371056 — intervention group
Group type: EXPERIMENTAL
Intervention: BCI-FES
Number of subjects: 25
Study 33371056 — intervention group
Group type: COMPARATOR
Intervention: FES
Number of subjects: 25
Study 35275009 — intervention group
Group type: EXPERIMENTAL
Intervention: Diperoxochloric acid (DPOCL)
Number of subjects: 289
Study 35275009 — intervention group
Group type: COMPARATOR
Intervention: Isotonic sodium chloride solution (ISCL)
Number of subjects: 289
Study 32345957 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-Enhanced Ultrasound (CEUS)
Number of subjects: 68
Study 32345957 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative Neurophysiological Monitoring (IONM)
Number of subjects: 68
Study 36322845 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acids at a dose of 1 g per day for 5 days after birth
Number of subjects: 434
Study 36322845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 434
Study 34582448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO) emollient therapy; 10 ml applied 3 times daily throughout the neonatal period.
Number of subjects: 26487
Study 34582448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO) emollient therapy (exclusive applications).
Number of subjects: 26487
Study 34582448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO) emollient therapy (subgroup of infants weighing ≤1,500 g).
Number of subjects: 26487
Study 34582448 — intervention group
Group type: COMPARATOR
Intervention: Mustard oil massage (usual care in comparison clusters).
Number of subjects: 26487
Study 34233350 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% Dakin's Solution (DS)
Number of subjects: 0
Study 34233350 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 0
Study 32458301 — intervention group
Group type: EXPERIMENTAL
Intervention: Condomless sex acts
Number of subjects: 5012
Study 32458301 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex acts with primary partners
Number of subjects: 5012
Study 32458301 — intervention group
Group type: COMPARATOR
Intervention: Sex acts with condoms
Number of subjects: 5012
Study 32458301 — intervention group
Group type: COMPARATOR
Intervention: Sex acts with non-primary partner
Number of subjects: 5012
Study 32458301 — intervention group
Group type: EXPERIMENTAL
Intervention: Count of sexual risk behaviors among different groups (WSM, MSW, MSM)
Number of subjects: 5012
Study 32737450 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant fluorouracil–levamisole in pMMR patients
Number of subjects: 544
Study 32737450 — intervention group
Group type: COMPARATOR
Intervention: Surgery-only group in pMMR patients
Number of subjects: 544
Study 32737450 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy group in pMMR patients
Number of subjects: 544
Study 32737450 — intervention group
Group type: EXPERIMENTAL
Intervention: pMMR/CDX2-negative cases
Number of subjects: 544
Study 32737450 — intervention group
Group type: EXPERIMENTAL
Intervention: pMMR patients with CDX2 negativity
Number of subjects: 544
Study 616609856 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message reminders sent to patients (320 patients)
Number of subjects: 641
Study 616609856 — intervention group
Group type: COMPARATOR
Intervention: No text message reminders (321 patients)
Number of subjects: 641
Study 616609856 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message reminders
Number of subjects: 641
Study 616609856 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients older than 50 years
Number of subjects: 641
Study 35103604 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert teleconsultations with intensivists and infectious disease specialists, available 24/7/365, once per week.
Number of subjects: 159424
Study 35103604 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 159424
Study 34814835 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert-based medication review with recommendations for drug discontinuation
Number of subjects: 579
Study 34814835 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 579
Study 34814835 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert-based medication review
Number of subjects: 579
Study 33493893 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided vacuum-assisted biopsy (UGVAB)
Number of subjects: 39
Study 33493893 — intervention group
Group type: COMPARATOR
Intervention: Surgical resection (SR)
Number of subjects: 39
Study 33493893 — intervention group
Group type: EXPERIMENTAL
Intervention: Both UGVAB and SR
Number of subjects: 39
Study 32447634 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 44
Study 32447634 — intervention group
Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 44
Study 35737384 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted colectomy (LAC)
Number of subjects: 943
Study 35737384 — intervention group
Group type: COMPARATOR
Intervention: Open colectomy (OC)
Number of subjects: 943
Study 32763619 — intervention group
Group type: EXPERIMENTAL
Intervention: Legal cynicism measurement
Number of subjects: 2680
Study 32763619 — intervention group
Group type: EXPERIMENTAL
Intervention: Legal cynicism antecedents
Number of subjects: 2680
Study 33941123 — intervention group
Group type: EXPERIMENTAL
Intervention: Work-related medical rehabilitation program (at least 11 hours of work-related treatment modules)
Number of subjects: 1800
Study 33941123 — intervention group
Group type: COMPARATOR
Intervention: Conventional psychosomatic rehabilitation program
Number of subjects: 1800
Study 32007177 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused extracorporeal shockwave therapy
Number of subjects: 79
Study 32007177 — intervention group
Group type: COMPARATOR
Intervention: Radial pressure wave therapy
Number of subjects: 79
Study 32101504 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise program (5 weeks, 19 sessions, 60 mins each)
Number of subjects: 58
Study 33151615 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% tomato lycopene and 3.45% wheat bran extract cream applied twice a day for three months with SPF 30 sunscreen
Number of subjects: 22
Study 33151615 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream applied twice a day for three months with SPF 30 sunscreen
Number of subjects: 22
Study 33197213 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 280
Study 33197213 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 280
Study 32036959 — intervention group
Group type: COMPARATOR
Intervention: HELP diet
Number of subjects: 144
Study 32036959 — intervention group
Group type: EXPERIMENTAL
Intervention: HELP + RSV diet (400 mg/kg)
Number of subjects: 144
Study 32036959 — intervention group
Group type: COMPARATOR
Intervention: Con diet
Number of subjects: 144
Study 35428645 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital behavioural health treatment for chronic pain
Number of subjects: 180
Study 35428645 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 180
Study 33482873 — intervention group
Group type: EXPERIMENTAL
Intervention: POCUS (point-of-care ultrasound) group
Number of subjects: 165
Study 33482873 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 165
Study 33482873 — intervention group
Group type: EXPERIMENTAL
Intervention: POCUS group
Number of subjects: 165
Study 32854200 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol, delivered in an online group format
Number of subjects: 60
Study 35396432 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33493453 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 12071
Study 33493453 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 12071
Study 32164906 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOXIRI plus bevacizumab
Number of subjects: 679
Study 32164906 — intervention group
Group type: COMPARATOR
Intervention: mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab
Number of subjects: 679
Study 35264337 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural writing therapy (iCBT)
Number of subjects: 34
Study 35264337 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 34
Study 33809130 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed (FS) dietary intervention, 10 g/d for 6 weeks
Number of subjects: 252
Study 32088670 — intervention group
Group type: EXPERIMENTAL
Intervention: Eucalyptus solution 5% inhalation 3 times/day for 20 minutes (every 8 hours)
Number of subjects: 100
Study 32088670 — intervention group
Group type: COMPARATOR
Intervention: Distilled water inhalation 3 times/day for 20 minutes (every 8 hours)
Number of subjects: 100
Study 32088670 — intervention group
Group type: EXPERIMENTAL
Intervention: Eucalyptus solution 5% inhalation
Number of subjects: 100
Study 32088670 — intervention group
Group type: COMPARATOR
Intervention: Distilled water inhalation
Number of subjects: 100
Study 34898009 — intervention group
Group type: EXPERIMENTAL
Intervention: e-learning (IG)
Number of subjects: 88
Study 34898009 — intervention group
Group type: COMPARATOR
Intervention: no e-learning (CG)
Number of subjects: 88
Study 33672666 — intervention group
Group type: EXPERIMENTAL
Intervention: Slowly processed pasta
Number of subjects: 14
Study 33672666 — intervention group
Group type: COMPARATOR
Intervention: Normally processed pasta
Number of subjects: 14
Study 35995135 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP) plus artesunate
Number of subjects: 305
Study 35995135 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine (AQ) plus artesunate
Number of subjects: 305
Study 35995135 — intervention group
Group type: COMPARATOR
Intervention: Control (no malaria treatment)
Number of subjects: 305
Study 33724643 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 120
Study 33724643 — intervention group
Group type: COMPARATOR
Intervention: Supportive Psychotherapy (SPT)
Number of subjects: 120
Study 32665529 — intervention group
Group type: EXPERIMENTAL
Intervention: Abaloparatide followed by alendronate
Number of subjects: 56
Study 32665529 — intervention group
Group type: COMPARATOR
Intervention: Placebo followed by alendronate
Number of subjects: 56
Study 36207685 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-Social Partnership Program (HSPP) with nurse-led case management and support from a social service team.
Number of subjects: 92
Study 36207685 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-Social Partnership Program (HSPP)
Number of subjects: 92
Study 33948660 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassion meditation (CM) program delivered by smartphone application
Number of subjects: 57
Study 33948660 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassion meditation (CM) program
Number of subjects: 57
Study 33948660 — intervention group
Group type: COMPARATOR
Intervention: Compassion meditation (CM) group
Number of subjects: 57
Study 33948660 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition (oxytocin)
Number of subjects: 57
Study 33948660 — intervention group
Group type: COMPARATOR
Intervention: Familiarity condition
Number of subjects: 57
Study 36482231 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 μg/kg alfentanil
Number of subjects: 300
Study 36482231 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 μg/kg alfentanil
Number of subjects: 300
Study 36482231 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 μg/kg alfentanil
Number of subjects: 300
Study 36482231 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control group A)
Number of subjects: 300
Study 36482231 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing doses of alfentanil (2, 3, 4 μg/kg)
Number of subjects: 300
Study 36482231 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 300
Study 33988896 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle interventions (ILIs)
Number of subjects: 5145
Study 33988896 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (Control)
Number of subjects: 5145
Study 32967598 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine drain insertion
Number of subjects: 43
Study 32967598 — intervention group
Group type: EXPERIMENTAL
Intervention: Seldom inserted drains
Number of subjects: 43
Study 32967598 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerns about bleeding and anticoagulation
Number of subjects: 43
Study 32967598 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine practice
Number of subjects: 43
Study 32967598 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume and time for drain removal
Number of subjects: 43
Study 32967598 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume alone for drain removal
Number of subjects: 43
Study 32967598 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume threshold for drain removal
Number of subjects: 43
Study 32967598 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative period for drain removal
Number of subjects: 43
Study 32967598 — intervention group
Group type: EXPERIMENTAL
Intervention: Consideration for randomized controlled trial
Number of subjects: 43
Study 36137676 — intervention group
Group type: EXPERIMENTAL
Intervention: QFR-guided PCI
Number of subjects: 3825
Study 36137676 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided PCI
Number of subjects: 3825
Study 36137676 — intervention group
Group type: EXPERIMENTAL
Intervention: QFR-guided PCI (deferred)
Number of subjects: 3825